You are here: Industry Insights > NHS

News List

NHS should invest in digital, AI, and robotics training pharmaphorum
February 13, 2019
The Topol Review of the training needs of the future NHS workforce has published its recommendations – including an increase in the number of clinicians trained to use digital, AI and robotics technologies.
Court backs NHS in hepatitis C procurement row with AbbVie pharmaphorum
January 22, 2019
A court has backed NHS England in a case where US pharma giant AbbVie had alleged that its procurement process for hepatitis C drugs was unfair.
NHS faces uphill battle in prevention – survey pharmaphorum
January 22, 2019
A new survey has revealed confusion amongst the UK public on how to maintain a healthy lifestyle, suggesting the NHS has a long way to go to meet its goal of more disease prevention.
NHS plans for UK medicines supply in no-deal Brexit pharmaceutical-technology
January 22, 2019
The UK National Health Service (NHS) has announced contingency plans to ensure there is no disruption to medicines supply for patients in the event of a no-deal Brexit....
Digital health innovators get boost in Yorkshire and Humber pharmaphorum
January 16, 2019
A new NHS-backed scheme is to turbo-charge digital health innovation across England’s Yorkshire and Humber and region.
Mental health services falling behind rest of NHS – report pharmaphorum
January 15, 2019
Mental health services in the UK are falling behind physical health services because of outdated commissioning services in the National Health Service, according to a new report.
NHS Long Term Plan: focus on R&D and digital innovation pharmaceutical-technology
January 08, 2019
NHS Long Term Plan to build upon the successes of the health service to data and create a ‘new service model for the 21st century’.
One in 20 GP appointments missed, costing £216m pharmatimes
January 04, 2019
NHS England is urging patients to cancel appointments rather than just not show up, after news has emerged that more than 15 million general practice appointments are being wasted each year because patients
NHS to fund Afinitor for TSC-related epilepsy pharmatimes
January 03, 2019
NHS England has announced that from April this year it will fund Novartis' Afinitor (everolimus) for patients living with Tuberous Sclerosis Complex (TSC)-related refractory epilepsy.
NHS U-turns on Afinitor for TSC-related epilepsy pharmaphorum
December 25, 2018
NHS England has reversed a previous decision and will be funding Novartis’ Afinitor (everolimus) for TSC-related refractory epilepsy from April 2019.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 44 45 Next page